We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ADIL

Price
0.25
Stock movement up
+0.00 (0.03%)
Company name
Adial Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
8.12M
Ent value
3.75M
Price/Sales
251.88
Price/Book
1.38
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-38.36%
1 year return
-62.03%
3 year return
-70.39%
5 year return
-60.51%
10 year return
-
Last updated: 2025-09-12

iO Charts is a Seeking Alpha partner

DIVIDENDS

ADIL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales251.88
Price to Book1.38
EV to Sales116.20

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count21.83M
EPS (TTM)-1.91
FCF per share (TTM)-0.80

Income statement

Loading...
Income statement data
Revenue (TTM)32.25K
Gross profit (TTM)-282.00
Operating income (TTM)-6.34M
Net income (TTM)-11.13M
EPS (TTM)-1.91
EPS (1y forward)-0.90

Margins

Loading...
Margins data
Gross margin (TTM)-0.87%
Operating margin (TTM)-19672.90%
Profit margin (TTM)-34505.55%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash5.20M
Net receivables0.00
Total current assets5.62M
Goodwill0.00
Intangible assets3.49K
Property, plant and equipment0.00
Total assets6.71M
Accounts payable318.12K
Short/Current long term debt0.00
Total current liabilities829.05K
Total liabilities829.05K
Shareholder's equity5.88M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-5.05M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-4.65M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-189.11%
Return on Assets-165.75%
Return on Invested Capital-189.11%
Cash Return on Invested Capital-78.96%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.38
Daily high0.39
Daily low0.36
Daily Volume426K
All-time high208.25
1y analyst estimate2.50
Beta1.01
EPS (TTM)-1.91
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ADILS&P500
Current price drop from All-time high-99.82%-1.46%
Highest price drop-99.89%-56.47%
Date of highest drop24 Jun 20259 Mar 2009
Avg drop from high-81.35%-10.99%
Avg time to new high148 days12 days
Max time to new high1660 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ADIL (Adial Pharmaceuticals Inc) company logo
Marketcap
8.12M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.
Employees
5
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...